3VM for Treatment of Chronic Osteoarthritis Knee Pain

Summary

A double-blind, placebo-controlled, randomized dose ranging study for the use of 3VM1001 Cream, 2g three times daily, 3g three times daily, or 3g four times daily for treatment of chronic pain associated with osteoarthritis of the knee compared to inactive placebo.

Timeline

Start

2017-04-30

Primary completion

2018-01-30

Completion

2018-06-01

Drugs

Indications